Arana G W, Goff D C, Baldessarini R J, Keepers G A
Department of Psychiatry, University of South Carolina, Charleston 29425.
Am J Psychiatry. 1988 Aug;145(8):993-6. doi: 10.1176/ajp.145.8.993.
The authors analyzed data from nine studies comparing the incidence of acute dystonia induced by neuroleptic agents with and without concomitant use of anticholinergic agents. Anticholinergic agents reduced the rate of dystonia by 1.9-fold in all patients treated with different neuroleptics and by 5- to 8-fold in patients treated with high-potency neuroleptics. In addition, the incidence of dystonia and the efficacy of anticholinergic prophylaxis were related inversely to age. These results support the efficacy of anticholinergic agents in preventing neuroleptic-induced dystonia, particularly in young male patients treated with high-potency neuroleptics.
作者分析了九项研究的数据,这些研究比较了使用和未使用抗胆碱能药物时,抗精神病药物诱发急性肌张力障碍的发生率。在所有接受不同抗精神病药物治疗的患者中,抗胆碱能药物使肌张力障碍的发生率降低了1.9倍;在接受高效能抗精神病药物治疗的患者中,该发生率降低了5至8倍。此外,肌张力障碍的发生率和抗胆碱能药物预防的疗效与年龄呈负相关。这些结果支持抗胆碱能药物在预防抗精神病药物诱发的肌张力障碍方面的疗效,尤其是在接受高效能抗精神病药物治疗的年轻男性患者中。